Comment on ‘Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism’

Mishka Terplan and Diana Zuckerman From the Journal of Family Planning & Reproductive Health Care Despite the increased interest in evidence-based medicine, many medical guidelines and statements of medical professionals are based primarily on opinion rather than scientific facts. The … Continue reading

FDA Kicks Off Women’s Health Program With Surgical Mesh Registry

FDA’s launch of a new registry for controversial surgical transvaginal mesh products as part of a new program focusing on women’s health could signal the agency is planning to prioritize sex-specific device concerns, a consumer advocate said. “If they start with new patients, it will take years before we get the information that we need,” said Diana Zuckerman, president of the National Research Center for Women & Families. Continue reading

The Op-Ed: FDA Panels: Too Many Conflicts Or Too Little Expertise?

June 2013. Should FDA Advisory Committee members be allowed to have financial conflicts of interest regarding the approval of medical products? Diana Zuckerman discusses how financial ties to pharmaceutical companies can influence the voting and discussion on drug and medical device approvals, and how misunderstandings of statistics and the value of clinical trials can lead to the approval of dangerous products. Continue reading

TN Compounder’s Steroid Sickens Patients

TN Compounder’s Steroid Sickens Patients – May 25, 2013 – “Nobody imagined that a company with the reassuringly named ‘Main Street Pharmacy’ could be shipping contaminated medical products to patients in 13 states,” said Diana Zuckerman, president of the National Research Center for Women and Families. “Unfortunately, the public is at just as much risk now as we were when patients first started dying from contaminated medicines last year.” Continue reading

Senate panel approves tighter oversight of compounding pharmacies, but bill is under fire

Washington Post. May 23, 2013. Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks. Continue reading

Angelina Jolie’s Decision

Huffington Post. 16 May 2013. Dr. Diana Zuckerman writes, “Let’s use Angelina Jolie’s announcement to have a frank discussion of the treatment choices for breast cancer and to encourage women to make decisions based on their own situations not on the choice of a celebrity, however admirable she is.” Continue reading

Breast implants as therapy? Not so much

Many girls and women want breast implants because they believe it will improve their self-esteem. It is true that cosmetic surgery can help a person feel better about the body part that was “fixed,” whether it is a breast, a nose, ears, or thighs. But research shows that breast implants do NOT improve self-esteem. In fact, several studies show that breast implants LOWER self-esteem even if it makes a woman feel sexier. Continue reading